HIVE vs WULF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

HIVE

39.5
AI Score
VS
WULF Wins

WULF

55.2
AI Score

Investment Advisor Scores

HIVE

40score
Recommendation
AVOID NEW MONEY

WULF

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE WULF Winner
Forward P/E 62.8931 212.766 HIVE
PEG Ratio 0 0 Tie
Revenue Growth 73.5% -6.0% HIVE
Earnings Growth -99.9% 0.0% WULF
Tradestie Score 39.5/100 55.2/100 WULF
Profit Margin -98.5% 0.0% WULF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD WULF

Relative Price Performance (Last 90 Days)

HIVE 1M: +7.2% · 3M: -13.8% WULF 1M: +2.8% · 3M: -31.4%

Current Technical Phase

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 44

RSI (14): 44.2 · Price: $2.92

WULF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.8%), weak momentum, RSI 44

RSI (14): 44.1 · Price: $15.24

Fundamentals Snapshot

Metric HIVE WULF
Market Cap — —
Forward P/E -5.7 -62.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.7% -0.1%
Gross Margin 0.4% 0.7%
Operating Margin -0.6% -3.1%
EPS -1.39 -4.46
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, WULF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.